Harbin Pharm. Group Sanjing Pharmaceutical Shareholding Co., Ltd. has predicted net loss of CNY 20 million to CNY 35 million in the first half of 2013. A year ago, the company made profit of CNY 223.4496 million.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
5.44 CNY | +0.74% |
|
-5.88% | -30.43% |
1st Jan change | Capi. | |
---|---|---|
-30.43% | 431M | |
+30.55% | 78.84B | |
+2.31% | 25.55B | |
+12.73% | 8.68B | |
+1.96% | 8.59B | |
-30.63% | 6.93B | |
+17.58% | 5.32B | |
+2.75% | 4.21B | |
-9.01% | 3.83B | |
+9.64% | 3.22B |
- Stock Market
- Equities
- 600829 Stock
- News HPGC Renmintongtai Pharmaceutical Corporation
- Harbin Pharm. Group Sanjing Pharmaceutical Shareholding Co., Ltd. Provides Earnings Guidance for the First Half of 2013